The chemical class called apoA-V Activators includes a range of compounds that indirectly influence the activity or expression of apoA-V. These chemicals primarily function through their effects on various aspects of lipid metabolism, a key area of apoA-V's involvement. For instance, compounds like fibrates and thiazolidinediones activate specific receptors such as PPARs, which play a crucial role in regulating genes involved in lipid metabolism. This regulation can influence the expression or activity of apoA-V, given its significant role in triglyceride homeostasis.
Additionally, other compounds such as statins and niacin, while primarily targeting other aspects of lipid metabolism, can have a secondary influence on the pathways involving apoA-V. The modulation of lipid profiles by these compounds can create a metabolic environment that affects the expression or function of apoA-V. Similarly, omega-3 fatty acids, known for their beneficial effects on lipid profiles, particularly triglycerides, can indirectly impact the activity of apoA-V. Other compounds like GLP-1 agonists, CETP inhibitors, and retinoids also contribute to this category by modulating various aspects of lipid metabolism and transport, thereby affecting apoA-V indirectly.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Activates PPARs, influencing genes in lipid metabolism which can impact apoA-V expression. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Influences lipid metabolism, altering lipid profiles and potentially affecting apoA-V. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
An omega-3 fatty acid that modulates lipid metabolism and can influence triglyceride levels, thereby affecting apoA-V. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
A statin that impacts cholesterol and triglyceride metabolism, potentially influencing apoA-V. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
A PPAR-gamma activator, modulates lipid metabolism, potentially affecting apoA-V. | ||||||
Liraglutide | 204656-20-2 | sc-507404 | 1 mg | $220.00 | ||
A GLP-1 agonist that influences glucose and lipid metabolism, potentially impacting apoA-V. | ||||||
Anacetrapib | 875446-37-0 | sc-364404 sc-364404A | 10 mg 50 mg | $615.00 $1785.00 | ||
A CETP inhibitor that modulates lipid transfer proteins, potentially impacting apoA-V through lipid profile changes. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Involved in regulating lipid metabolism, could influence apoA-V. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A polyphenol known for antioxidative properties, influences lipid metabolism, potentially affecting apoA-V. | ||||||
CHOLESTYRAMINE RESIN | 11041-12-6 | sc-507509 | 5 g | $210.00 | ||
A bile acid sequestrant influencing lipid absorption and metabolism, potentially impacting apoA-V. | ||||||